How I treat prolymphocytic leukemia

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

(2011) C. E. Dearden et al.   BLOOD

Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia

(2011) Kai Uwe Chow et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia

(2011) M. Montagna et al.   HAEMATOLOGICA

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium

(2011) W Wiktor-Jedrzejczak et al.   LEUKEMIA

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

(2010) V. J. Weston et al.   BLOOD

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia

(2010) Junia V. Melo et al.   BRITISH JOURNAL OF HAEMATOLOGY

Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study

(2010) Biju Krishnan et al.   BRITISH JOURNAL OF HAEMATOLOGY

2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders

(2010) D. Rondelli et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Allogeneic Hematopoietic Cell Transplant for Prolymphocytic Leukemia

(2009) Matt E. Kalaycio et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A–TCRAD juxtaposition

(2009) Stefanie Bug et al.   CANCER GENETICS AND CYTOGENETICS

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

(2009) A. Mozos et al.   HAEMATOLOGICA

Phase II Study of Alemtuzumab in Combination With Pentostatin in Patients With T-Cell Neoplasms

(2009) Farhad Ravandi et al.   JOURNAL OF CLINICAL ONCOLOGY

B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures

(2009) I Del Giudice et al.   LEUKEMIA

Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms

(2009) Yi-Hua Chen et al.   MODERN PATHOLOGY

A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia

(2008) Adrian Tempescul et al.   ANNALS OF HEMATOLOGY

Phase I Trial of Nelarabine in Indolent Leukemias

(2008) Varsha Gandhi et al.   JOURNAL OF CLINICAL ONCOLOGY